Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation.

BACKGROUND AND PURPOSE The aim of this study was to assess the feasibility of using gold seed implants in the prostate for position verification, using an a-Si flat panel imager as a detector during megavoltage irradiation of prostate carcinoma. This is a study to guarantee positioning accuracy in intensity-modulated radiotherapy. METHODS AND MATERIALS Ten patients with localized prostate carcinoma (T2-3) received between one and three fiducial gold markers in the prostate. All patients were treated with 3-D conformal radiotherapy with an anterior-posterior (AP) and two lateral wedge fields. The acute gastrointestinal (GI) and genitourinary (GU) toxicities were scored using common toxicity criteria scales (CTC). Using three consecutive CT scans and portal images obtained during the treatment we have studied the occurrence of any change in prostate shape (deformation), seed migration and the magnitude of translations and rotations of the prostate. RESULTS We observed no acute major complications for prostate irradiation regarding the seed implantation. The maximum acute GU toxicity grade 2 (dysuria and frequency) was observed in seven patients during the treatment. The maximum grade 2 (diarrhoea) was scored in two patients regarding the acute GI toxicities. No significant prostate deformation could be detected in the consecutive CT scans. It appeared that the distances between the markers only slightly changed during treatment (S.D. 0.5 mm). Random prostate translations were (1 S.D.) 2.1, 3.2 and 2.2 mm in the lateral (LR), AP and cranial-caudal (CC) directions, respectively, whereas systematic translations were 3.3, 4.8 and 3.5 mm in the LR, AP and CC directions, respectively. Random prostate rotations were (1 S.D.) 3.6, 1.7 and 1.9 degrees around the LR, AP and CC axis, respectively, whereas systematic rotations were 4.7, 2.0 and 2.7 degrees around the LR, AP and CC axis, respectively. CONCLUSIONS We found that the fiducial gold seeds are a safe and appropriate device to verify and correct the position of prostate during megavoltage irradiation. The amount of seed migration and prostate deformation is far below our present tumour delineation accuracy.

[1]  Jan J W Lagendijk,et al.  Measurements and clinical consequences of prostate motion during a radiotherapy fraction. , 2002, International journal of radiation oncology, biology, physics.

[2]  K L Lam,et al.  Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. , 1995, International journal of radiation oncology, biology, physics.

[3]  L. Verhey,et al.  Computer-assisted positioning of radiotherapy patients using implanted radiopaque fiducials. , 1993, Medical physics.

[4]  M van Herk,et al.  Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.

[5]  M. Aron,et al.  Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study , 2000, BJU international.

[6]  P Hofman,et al.  Feasibility of automatic marker detection with an a-Si flat-panel imager. , 2001, Physics in medicine and biology.

[7]  J C Stroom,et al.  Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.

[8]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[9]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[10]  William R. Fair,et al.  DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER , 1998 .

[11]  H M Sandler,et al.  Localization of the prostatic apex for radiation therapy using implanted markers. , 1993, International journal of radiation oncology, biology, physics.

[12]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[13]  H. Shirato,et al.  Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. , 2000, International journal of radiation oncology, biology, physics.

[14]  H. Sandler,et al.  Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. , 1995, International journal of radiation oncology, biology, physics.

[15]  T Haycocks,et al.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[17]  Joos V Lebesque,et al.  Margins for translational and rotational uncertainties: a probability-based approach. , 2002, International journal of radiation oncology, biology, physics.

[18]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.

[19]  Randall K Ten Haken,et al.  Daily prostate targeting using implanted radiopaque markers. , 2001, International journal of radiation oncology, biology, physics.

[20]  C. Ling,et al.  Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[21]  J C Stroom,et al.  Internal organ motion in prostate cancer patients treated in prone and supine treatment position. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  L. Gras,et al.  Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms. , 1998, International journal of radiation oncology, biology, physics.